Evidence map›Paper›PMID 25044035›Full record

ReviewMagnetic resonance in medicine2015

Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.

Yi Wang, Tian Liu

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Magnetic resonance in medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07759895 (Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia), which is not on this map. Cited by 454 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
454citing papers in PubMed, 2 pooled it
41.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07759895 phase2not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia

TypeinterventionalSponsorAmit LotanRan2026 to 2029Enrolled80ConditionsSchizoaffecitve Disorder, Schizophrenia and Schizoaffective Disorder, Schizophrenia and Predominant Negative SymptomsArmsDeferiprone (DFP), N-Acetyl Cysteine (NAC)
3 · Its place in the literature

Who cites it

454 citing papers in PubMed, 2 syntheses or guidelines pooled it, 850 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Simultaneous 3-D Adiabatic TNMR in biomedicine · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

394 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Yi WangRadiology, Weill Medical College of Cornell University, New York, New York, USA.
Tian LiuMedImageMetric, LLC, New York, New York, USA.
Cornell University · US

Funding

MRI method for quantitatively mapping cerebral microbleedsR01NS072370 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI WANG, YI · 2011 to 2015
$1.8M
Theranostic nanoparticles for the treatment of RAI refractory thyroid cancerR01CA178007 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI JIN, MOONSOO M., WANG, YI · 2013 to 2017
$1.7M
Analyses of gradient echo MRI dataR01EB013443 · NIBIB · WEILL MEDICAL COLL OF CORNELL UNIV · PI WANG, YI · 2011 to 2014
$1.5M
A Novel Quantification Tool for Molecular MRIR43EB015293 · NIBIB · MEDIMAGEMETRIC, LLC · PI LIU, TIAN, WANG, YI · 2012 to 2012
$169k
International Workshop on MRI Phase Contrast and Quantitative Susceptibility MappR13NS079016 · NINDS · CORNELL UNIVERSITY · PI WANG, YI · 2012 to 2012
$20k
NCI NIH HHS R01 CA178007NCI NIH HHS R01CA178007NIBIB NIH HHS R01 EB013443NIBIB NIH HHS R01EB013443NIBIB NIH HHS R43 EB015293NIBIB NIH HHS R43EB015293NINDS NIH HHS R01 NS072370NINDS NIH HHS R01NS072370NINDS NIH HHS R13 NS079016NINDS NIH HHS R13NS079016
6 · The paper itself

Abstract

In MRI, the main magnetic field polarizes the electron cloud of a molecule, generating a chemical shift for observer protons within the molecule and a magnetic susceptibility inhomogeneity field for observer protons outside the molecule. The number of water protons surrounding a molecule for detecting its magnetic susceptibility is vastly greater than the number of protons within the molecule for detecting its chemical shift. However, the study of tissue magnetic susceptibility has been hindered by poor molecular specificities of hitherto used methods based on MRI signal phase and T2* contrast, which depend convolutedly on surrounding susceptibility sources. Deconvolution of the MRI signal phase can determine tissue susceptibility but is challenged by the lack of MRI signal in the background and by the zeroes in the dipole kernel. Recently, physically meaningful regularizations, including the Bayesian approach, have been developed to enable accurate quantitative susceptibility mapping (QSM) for studying iron distribution, metabolic oxygen consumption, blood degradation, calcification, demyelination, and other pathophysiological susceptibility changes, as well as contrast agent biodistribution in MRI. This paper attempts to summarize the basic physical concepts and essential algorithmic steps in QSM, to describe clinical and technical issues under active development, and to provide references, codes, and testing data for readers interested in QSM.

Indexed as

AlgorithmsBiomarkersFemaleHumansImage EnhancementImage Interpretation, Computer-AssistedMagnetic Resonance ImagingMaleMolecular ImagingReproducibility of ResultsSensitivity and SpecificityBiomarkersBayesiancalcificationcontrast agentdipole fielddipole kernelferritingradient echohemoglobinhemorrhageironmetabolismmorphology enabled dipole inversionmyelinoxygen consumptionQSMquantificationquantitative susceptibility mapping

Identifiers

PMID25044035
PMCPMC4297605
OpenAlexW2050900769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.